Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Albrecht

Showing results (171-180 of 245) with videos related to

Pageof 25
Sort By:
Arthritis and Rheumatism|August 29, 2009
Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot projectM Backhaus, S Ohrndorf, H Kellner, et al.
Pharmacogenetics and Genomics|September 25, 2013
Predictors of consent to pharmacogenomics testing in the IDEAL studyAlison B Jazwinski, Paul J Clark, Alexander J Thompson, et al.
Alimentary Pharmacology & Therapeutics|December 18, 2007
Clinical trial: interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis CJ G McHutchison, K Patel, E R Schiff, et al.
Hepatology (Baltimore, Md.)|March 1, 2002
Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirinJohn G McHutchison, Thierry Poynard, Rafael Esteban-Mur, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery and Optimization of Tetramethylpiperidinyl Benzamides as Inhibitors of EZH2Christopher G Nasveschuk, Alexandre Gagnon, Shivani Garapaty-Rao, et al.
Organic Letters|July 29, 2014
A practical synthesis of indoles via a Pd-catalyzed C-N ring formationRishi G Vaswani, Brian K Albrecht, James E Audia, et al.
Gastroenterology|March 4, 2003
Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized studyDidier Samuel, Thierry Bizollon, Cyrille Feray, et al.
Journal of Hepatology|November 20, 2012
Improved inflammatory activity with peginterferon alfa-2b maintenance therapy in non-cirrhotic prior non-responders: a randomized studyThierry Poynard, Jordi Bruix, Eugene R Schiff, et al.
Journal of Hepatology|November 28, 2012
Efficacy and safety of boceprevir plus peginterferon-ribavirin in patients with HCV G1 infection and advanced fibrosis/cirrhosisSavino Bruno, John M Vierling, Rafael Esteban, et al.
Zeitschrift Fur Rheumatologie|March 5, 2014
[Evidence-based recommendations for the management of undifferentiated peripheral inflammatory arthritis (UPIA). The German perspective on the international 3e initiative]I H Tarner, K Albrecht, M Fleck, et al.
Pageof 25

Showing results (171-180 of 245) with videos related to

Sort By:
Pageof 25
Arthritis and Rheumatism|August 29, 2009
Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot projectM Backhaus, S Ohrndorf, H Kellner, et al.
Pharmacogenetics and Genomics|September 25, 2013
Predictors of consent to pharmacogenomics testing in the IDEAL studyAlison B Jazwinski, Paul J Clark, Alexander J Thompson, et al.
Alimentary Pharmacology & Therapeutics|December 18, 2007
Clinical trial: interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis CJ G McHutchison, K Patel, E R Schiff, et al.
Hepatology (Baltimore, Md.)|March 1, 2002
Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirinJohn G McHutchison, Thierry Poynard, Rafael Esteban-Mur, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery and Optimization of Tetramethylpiperidinyl Benzamides as Inhibitors of EZH2Christopher G Nasveschuk, Alexandre Gagnon, Shivani Garapaty-Rao, et al.
Organic Letters|July 29, 2014
A practical synthesis of indoles via a Pd-catalyzed C-N ring formationRishi G Vaswani, Brian K Albrecht, James E Audia, et al.
Gastroenterology|March 4, 2003
Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized studyDidier Samuel, Thierry Bizollon, Cyrille Feray, et al.
Journal of Hepatology|November 20, 2012
Improved inflammatory activity with peginterferon alfa-2b maintenance therapy in non-cirrhotic prior non-responders: a randomized studyThierry Poynard, Jordi Bruix, Eugene R Schiff, et al.
Journal of Hepatology|November 28, 2012
Efficacy and safety of boceprevir plus peginterferon-ribavirin in patients with HCV G1 infection and advanced fibrosis/cirrhosisSavino Bruno, John M Vierling, Rafael Esteban, et al.
Zeitschrift Fur Rheumatologie|March 5, 2014
[Evidence-based recommendations for the management of undifferentiated peripheral inflammatory arthritis (UPIA). The German perspective on the international 3e initiative]I H Tarner, K Albrecht, M Fleck, et al.
Pageof 25